BioControl Medical receives FDA approval to initiate second phase of CardioFit ... News-Medical.net BioControl Medical has announced U.S. Food and Drug Administration approval to begin the second phase of INOVATE-HF (INcrease Of VAgal TonE in Heart Failure), a global, multi-center, investigational device exemption (IDE) clinical study of the ... |
